Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Oil prices dropped for a fourth straight session, reaching levels not seen since before the onset of the U.S.-Iran conflict. Improved transit through the Strait of Hormuz and signals that Iranian exports could resume under temporary sanctions relief trimmed a large portion of the geopolitical risk premium, even as U.S. fuel stock data showed mixed …
Quantum-Si Inc. (NASDAQ:QSI) Chief Financial Officer Jeffry Keyes completed the sale of company shares totaling $7,641 on June 22 and June 23, 2026. These transactions were executed under a mandatory sell-to-cover provision designed to satisfy federal, state, and local withholding taxes associated with the vesting of restricted stock units. The CFO…
Jean Francois Formela, a director at Korro Bio, Inc. (NASDAQ:KRRO), has executed the sale of approximately $2.46 million worth of common stock over a three-day period in late June 2026. The transactions, which involved the disposition of 171,405 shares, were conducted under a Rule 10b5-1 trading plan adopted earlier in the year. The shares were hel…
John Zahurancik, serving as Senior Vice President and Chief Commercial and Strategy Officer at Fluence Energy, Inc. (NASDAQ:FLNC), recently executed two separate sales of company stock on June 22 and June 23, 2026. These transactions resulted in the disposal of approximately $754,702 worth of Class A Common Stock. The sales occurred against a backd…
John S. Vieceli, Chief Product Officer at Quantum-Si Inc (NASDAQ:QSI), executed two mandatory stock sales totaling $28,052 in late June 2026 to cover withholding taxes on vesting restricted stock units. The transactions occurred amid a period of significant stock volatility, with shares trading near $0.83. Despite recent operational milestones, inc…
ServiceNow is a high-quality enterprise SaaS business that has pulled back from its 52-week high and now trades at attractive entry levels for investors willing to tolerate near-term macro and sentiment noise. The company's Now Platform, growing AI commitments and strong free cash flow offer a catalyst-rich path to a return to double-digit revenue …
Carl Dambkowski, Chief Medical Officer of Apogee Therapeutics, Inc. (NASDAQ:APGE), executed a sale of 26,400 shares on June 22, 2026, generating approximately $3.5 million. The transaction, governed by a pre-established Rule 10b5-1 plan adopted in September 2025, occurred as Apogee's stock approached a 52-week high of $133.16. This activity unfolds…
Evommune, Inc. (NASDAQ:EVMN) Chief Scientific Officer Jeegar Pravinkumar Patel executed a transaction involving the sale of 1,488 shares of company common stock on June 22, 2026, totaling $33,480. The sale was conducted under a Rule 10b5-1 trading plan adopted earlier in the year, coinciding with the exercise of 1,488 employee stock options at $3.8…
U.S. stock index futures climbed notably in late trading after Micron and Qualcomm issued upbeat guidance tied to artificial intelligence demand. The move followed a mostly negative regular session marked by a sharp pullback in technology names earlier in the week. Traders now look to upcoming PCE inflation and GDP data for further direction on int…
Quantum-Si Inc. (NASDAQ: QSI) Chief Executive Officer Jeffrey Alan Hawkins completed two stock sales in late June 2026, generating approximately $20,996 to cover mandatory tax withholdings associated with restricted stock unit vesting. The transactions occurred as the company reported better-than-expected first-quarter results and announced a new c…
MARA Holdings, Inc. (NASDAQ:MARA) director Douglas K. Mellinger executed a stock sale on June 22, 2026, selling 7,000 shares at $16.00 per share, totaling $112,000. The transaction was carried out under a Rule 10b5-1 trading plan established on March 6, 2025. Following the sale, Mellinger directly holds 231,618 shares and indirectly holds 15,000 sh…
Capricor Therapeutics, Inc. (NASDAQ: CAPR) reported the execution of a pre-arranged trading plan by its Chief Financial Officer, Anthony Bergmann. The sale of 900 shares was facilitated by options exercised from a long-term vesting schedule, following the adoption of the 10b5-1 plan in late 2025. This activity occurs against a backdrop of recent fi…
Michael Henderson, Chief Executive Officer of Apogee Therapeutics, Inc. (NASDAQ: APGE), executed a sale of 80,000 shares of the company's common stock on June 22, 2026. The transaction, valued at approximately $10.6 million, was conducted through a Rule 10b5-1 trading plan established earlier in the year. The sale occurred as APGE's stock traded ne…
Abercrombie & Fitch is trading at a single-digit P/E and attractive EV multiples while reporting steady top-line growth and strong free cash flow. Recent beats, a Hollister collaboration with Target and explicit buyback plans provide near-term catalysts. This trade idea outlines an actionable long with entry, stop and target for a 180-trading-day h…
Janice Suzann Drew, Chief of Development Operations at Evommune, Inc. (NASDAQ:EVMN), executed a significant sale of company stock on June 22, 2026. The transaction, valued at $452,600, followed the exercise of employee stock options earlier the same day. This activity occurs against a backdrop of positive clinical trial developments and financial r…
Christian Kleinerman, Executive Vice President of Product Management at Snowflake Inc. (NASDAQ: SNOW), has executed a series of stock transactions involving the company’s common stock, as disclosed in recent filings. These transactions include both sales under a pre-arranged trading plan and shares withheld for tax obligations. The activity occurs …
Omada Health, Inc. (NASDAQ:OMDA) President Shao Wei-Li executed a share sale under a pre-arranged 10b5-1 trading plan, while the company reported first-quarter 2026 financial results that beat earnings forecasts and saw significant revenue growth. Concurrently, Citizens raised its price target for the stock, and the company completed its 2026 Annua…
HUTCHMED announced pivotal Phase II trial results for fanregratinib in treating advanced intrahepatic cholangiocarcinoma (ICC) patients harboring FGFR2-fusions or rearrangements. The single-arm trial in China demonstrated a 42.5% objective response rate, rapid onset, durable disease control, and a manageable safety profile. Based on these results, …
Fund 1 Investments, LLC, a significant 10% shareholder in Citi Trends Inc (NASDAQ: CTRN), executed a substantial divestiture of its holdings in the apparel retailer. The transaction involved the sale of 750,000 shares on June 24, 2026, totaling approximately $42.37 million. This reduction in ownership occurs against a backdrop of strong recent perf…
Yvonne Wassenaar, a member of the board of directors at Rubrik, Inc. (NASDAQ: RBRK), recently completed the sale of 676 shares of the company's Class A Common Stock. The transaction, valued at $50,700, was executed on June 23, 2026, at a price of $75.00 per share. This disposition was carried out in accordance with a Rule 10b5-1 trading plan that W…
Investment vehicles managed by OrbiMed Advisors LLC have executed a substantial divestment in Enliven Therapeutics, Inc. (NASDAQ: ELVN), selling approximately $39 million worth of common stock. The transaction, recorded on June 22, 2026, involved the disposal of 860,123 shares at prices between $45.00 and $45.38. This sale occurs as Enliven's stock…
Enerflex Ltd. has extended the maturity date of its $800 million revolving credit facility by three years to June 30, 2029, with increased borrowing capacity, demonstrating strong lender support and financial flexibility. The company plans to release its second quarter 2026 financial and operational results on August 6, 2026, accompanied by a confe…
CoreWeave, Inc. (CRWV) Chief Development Officer Brannin McBee executed a series of stock sales on June 22, 2026, moving 28,000 shares of Class A Common Stock through two distinct irrevocable trusts. The transactions, valued at approximately $3.1 million, were conducted under a Rule 10b5-1 trading plan established in March 2026. This activity occur…
Daniel D. Long, Septerna’s Senior Vice President of Drug Discovery, executed a series of structured equity transactions on June 22, 2026, selling $532,581 in company stock under a Rule 10b5-1 plan. The sale occurred while the stock traded near $36.05, close to its 52-week high of $37.99, following a 237% annual gain. The transactions were part of a…
CoreWeave, Inc. (NASDAQ: CRWV) reports executive stock divestment under a Rule 10b5-1 framework, coinciding with a broader corporate strategy focused on AI infrastructure expansion and capital raising. The transaction details, shareholding structure, and recent corporate developments provide a snapshot of the company's operational and financial pos…
